Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets
Aging · 2023
DOI: 10.18632/aging.204591 ↗At a glance
Journal article in Aging, 2023. Written by Fei Jiang and 13 co-authors. Institution: Department of General Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui, China. Major MEDLINE topics: Neoplasms. Cited 5 times so far (Crossref); 35 references. The full text is freely available in PubMed Central.
Abstract (original language)
Abstract non disponibile.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of General Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui, China.
- Hepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Pathology, Anhui Medical University, Hefei, Anhui, China.
- Department of Oncology, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui, China.
- School of Basic Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.
- The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Cite
APA
Jiang, F., Shi, Y., Wang, Y., Ge, C., Zhu, J., Fang, H., Zhang, Y., Zhang, Y., Jian, H., Lei, T., Lan, S., Cao, L., Yu, H., & Fang, D. (2023). Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets. Aging. https://doi.org/10.18632/aging.204591
Vancouver
Jiang F, Shi Y, Wang Y, Ge C, Zhu J, Fang H, et al. Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets. Aging. 2023. doi:10.18632/aging.204591
BibTeX
@article{Jiang2023,
author = {Jiang, Fei and Shi, Yanlong and Wang, Yue and Ge, Chang and Zhu, Jun and Fang, Hanlu and Zhang, Yu and Zhang, Yixiao and Jian, Haokun and Lei, Tong and Lan, Sheng and Cao, Liyu and Yu, Hongzhu and Fang, Debao},
title = {Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.204591}
}
EUVIMED